Phibro Animal Health (PAHC) Tops Q1 EPS by 16c
FREE Breaking News Alerts from StreetInsider.com!
- Wall St ends mixed as tech megacap declines outweigh upbeat chip outlook
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- IBM surges on unveiling sub-1nm chip technology breakthrough
- 'Long-term deals significant positive for stock:' Analysts react to Micron results
- Two major earthquakes strike Venezuela, killing at least 32 and injuring hundreds
- Needham Starts NeoVolta (NEOV) at Buy
- Hertz cuts guidance, announces notes and stock offerings, shares sink
- Rockstar Games opens GTA VI pre-orders, priced at $79.99
- Rubio meets Gulf leaders, pledges security amid Iran deal doubts
Phibro Animal Health Corporation Reports First Quarter
November 11, 2014 4:15 PM ESTTEANECK, N.J., Nov. 11, 2014 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (Nasdaq: PAHC) today announced its financial results for its first quarter ended September 30, 2014. It also updated guidance for its fiscal year ending June 30, 2015.
Highlights for the September 2014 quarter (compared to the September 2013 quarter) Net sales of $187 million, an increase of 16% Adjusted EBITDA of $30 million, an increase of 41% Adjusted diluted EPS of $0.51 Â Â Â Â Guidance for the June 2015 fiscal year (compared to the June 2014 fiscal year) updated to reflect an increase of $4 million attributable to accelerated licensing revenue and profit for... More